Warfarin pharmacogenetics
Phase 4
- Conditions
- Genetic Diseases
- Registration Number
- PACTR202103893112947
- Lead Sponsor
- Ilhaam Fredericks
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Age > 18 years old
Patients who require warfarin anticoagulation as part of standard of care
Exclusion Criteria
Patients who do not have informed consent
Patients with mechanical heart valves
Patients who were anticoagulated with warfarin in the last 30 days
Patients with liver failure
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method